FREE-ENERGY CALCULATIONS ON PROTEIN STABILITY - THR-157-] VAL-157 MUTATION OF T4 LYSOZYME
FREE-ENERGY CALCULATIONS ON PROTEIN STABILITY - THR-157-] VAL-157 MUTATION OF T4 LYSOZYME
复制标题
DOI:
10.1021/ja00204a027
复制
发表时间:
1989-10-25
影响因子:
15
通讯作者:
KOLLMAN, PA
中科院分区:
文献类型:
--
作者:
DANG, LX;MERZ, KM;KOLLMAN, PA
We present free energy perturbation calculations on the X-ray structure of native T4 lysozyme, the Thr-157—Val-157 mutant of T4 lysozyme, and on a tetrapeptide model that represents the denaturedstate of the native and mutant enzymes. This is the first free energy perturbation calculation on protein stability in a case where a precise comparison with experiment can be made. The relative calculated free energy difference between native and denatured models for nativeand the Thr— Val mutant was 1.9±1.1 kcal/mol. Thisvalue is in good agreement with the experimental value of 1.6 kcal/mol, supporting our approach. Contrary to expectation, the van der Waals rather than the electrostatic component of the computed free energy is the dominant determinant of this differential stability. Thestructures that emerge from the simulations after mutation differ in important ways from the X-ray structures. This emphasizes the difficulties in reproducing X-ray structure with incomplete protein representation as well as limited simulation times (40 ps here). Nonetheless, the hydrogen-bonding patterns in the simulated structures are physically reasonable.T4 lysozyme has become the paradigm for the study of the dependence of protein stability on protein sequence and threedimensional structure. 1 Both the X-ray structures and the thermodynamics of denaturation of the protein and many mutants are available. 2 Thus the question can be posed: Can theoretical molecular dynamics/free energy perturbation methods simulate the relative free energies of protein stability and the differences in X-ray structures of native and mutant enzymes? These free energy methods have been shown to be very useful in studies of solvation free energies, 3· 4 effect on drug structure of protein-ligand binding, 5 and effect of site-specific mutations on enzyme ligand binding andcatalysis. 6· 7